Modulation of age-related insulin sensitivity by VEGF-dependent vascular plasticity in adipose tissues

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 41, 2014, Pages 14906-14911

  Honek, Jennifer ^a   Seki, Takahiro ^a   Iwamoto, Hideki ^a   Fischer, Carina ^a   Li, Jingrong ^b   Lim, Sharon ^a   Samani, Nilesh J ^c   Zang, Jingwu ^b   Cao, Yihai ^a,c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Jiangsu Simcere Pharmaceutical Research Institute   (China)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Aging; Angiogenesis; Endothelial cells; Metabolic disorders; Vascularization

Indexed keywords

LIPID; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; AGING; ANIMAL; BLOOD; BROWN ADIPOSE TISSUE; C57BL MOUSE; CELL SIZE; CELL SURVIVAL; DRUG EFFECTS; FEMALE; INSULIN RESISTANCE; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; AGING; ANIMALS; CELL SIZE; CELL SURVIVAL; FEMALE; INSULIN RESISTANCE; LIPIDS; MICE, INBRED C57BL; OBESITY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84907894707     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1415825111     Document Type: Article

References (33)

1. Facchini FS, Hua N, Abbasi F, Reaven GM (2001) Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86(8):3574-3578.
2. Johnson AM, Olefsky JM (2013) The origins and drivers of insulin resistance. Cell 152(4):673-684.
3. Powell K (2007) Obesity: The two faces of fat. Nature 447(7144):525-527.
4. Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444(7121):881-887.
5. Cao Y (2010) Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9(2):107-115.
6. Cao Y (2013) Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. Cell Metab 18(4):478-489.
7. Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117(9):2362-2368.
8. Tang W, et al. (2008) White fat progenitor cells reside in the adipose vasculature. Science 322(5901):583-586.
9. Gupta RK, et al. (2012) Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 15(2):230-239.
10. Tran KV, et al. (2012) The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab 15(2):222-229.
11. Xue Y, et al. (2009) Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab 9(1):99-109.
12. Sung HK, et al. (2013) Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab 17(1):61-72.
13. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070):967-974.
14. Cao Y (2009) Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2(59):re1.
15. Alon T, et al. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1(10):1024-1028.
16. Cao Y, et al. (2011) Forty-year journey of angiogenesis translational research. Sci Transl Med 3:114rv113.
17. Cao Y, Langer R (2010) Optimizing the delivery of cancer drugs that block angiogenesis. Sci Transl Med 2(15):ps3.
18. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358(19):2039-2049.
19. Yang X, et al. (2013) Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth. Proc Natl Acad Sci USA 110(34):13932-13937.
20. Yang Y, et al. (2013) Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci USA 110(29):12018-12023.
21. Xue Y, et al. (2008) Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proc Natl Acad Sci USA 105(47):18513-18518.
22. Cao Y (2014) Angiogenesis as a therapeutic target for obesity and metabolic diseases. Chem Immunol Allergy 99:170-179.
23. Lim S, et al. (2012) Cold-induced activation of brown adipose tissue and adipose angiogenesis in mice. Nat Protoc 7(3):606-615.
24. Xue Y, Lim S, Bra˚kenhielm E, Cao Y (2010) Adipose angiogenesis: Quantitative methods to study microvessel growth, regression and remodeling in vivo. Nat Protoc 5(5):912-920.
25. Kim YM, et al. (2007) Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732. J Mol Endocrinol 38(4):455-465.
26. Bra˚kenhielm E, et al. (2004) Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94(12):1579-1588.
27. Rupnick MA, et al. (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99(16):10730-10735.
28. Elias I, et al. (2012) Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 61(7):1801-1813.
29. Sun K, et al. (2012) Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci USA 109(15):5874-5879.
30. Lu X, et al. (2012) Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. Endocrinology 153(7):3123-3132.
31. Ferrara N, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439-442.
32. Rosenbaum M, Leibel RL, Hirsch J (1997) Obesity. N Engl J Med 337(6):396-407.
33. Hill JO, Peters JC (1998) Environmental contributions to the obesity epidemic. Science 280(5368):1371-1374.